AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale
2
Wiz shareholders finalizing secondary deals worth hundreds of millions of dollars
3
Bill Ackman: "Israel needs support more than ever and I can help"
4
Cyber decacorn Wiz in advanced negotiation to acquire Lacework for $150-200 million
5
Guardians of innovation: The rise of Israel’s civilian defense-tech
More news

Medical

20 stories about Medical
חסימת השורה הראשונה באוטובוסים בשל הקורונה

With 76 Corona Cases, Israeli Ministry of Health Expands Restrictions

11.03.20|CTech
As the police sets up teams to make sure potential carriers stay at home, gatherings of over 2,000 have been forbidden
קורונה וירוס חיטוי באוטובוס של חברת דן תחבורה ציבורית

Coronavirus: Five Reasons for Optimism

10.03.20|Adi Barak and Tamar Tunik
Covid-19 has already spread to 115 countries and territories around the world, but not everything is bleak. Compared to the 2008 crisis, the financial system is more stable; compared to SARS, medical technology is more advanced
מתחם הבידוד לחולי קורונה בשיבא

Israel’s Health Ministry Takes Action to Stop Hospitals From Being Overrun

05.03.20|Adrian Filut and Omri Milman
Low public investment in infrastructure and understaffed hospitals will turn wide-spread coronavirus into a domestic nightmare. To flatten the infection curve, Israel is taking steps that may be among the harshest globally, to the displeasure of its finance ministry
קורונה וירוס סניף הפיראט האדום באור יהודה עובר חיטוי קורונה וירוס

From the Toy Store to the Soccer Game, How Coronavirus Spread in Israel

04.03.20|CTech
A shop owner who returned from Italy and went to work for three days has been connected to infections that have already shut down a school and sent 77 soccer spectators into quarantine
בניין ה בורסה משכן חדש רחוב אחוזת בית תל אביב

Biomed Company CartiHeal Considers a Nasdaq IPO

26.02.20|Golan Hazani
The company is looking to raise between $60 million and $80 million according to a valuation of $300 million to $400 million and has already hired Credit Suisse and Jefferies for this purpose, according to two people familiar with the matter
נגיף קורונה חברות תעופה חיטוי טיסות

Coronavirus Could Empty the Coffers of the Israeli Health System

25.02.20|Adrian Filut
The Israeli Ministry of Health has already been given $16.34 million for virus-related preparations, but that money is coming out of its budget for the rest of 2020
חברה ישראלית אינומק Inomec מכשירים רפואיים

Integer Acquires Medical Device Company Inomec

20.02.20|Hagar Ravet
Inomec develops and manufactures a wide array of medical devices, including laparoscopy systems, catheters, devices for brain and head surgery, imaging technology, and veterinary devices
ציפי עוזר ערמון מנכלית לומינס

Private Equity Firm Baring Completes $1.2 Billion Lumenis Acquisition

20.02.20|Golan Hazani
In November, Calcalist reported the company signed an MoU for Lumenis’ acquisition from London-based XIO Group
לקוחה מתנסה ב מחשב ש מעניק אינפורמציה על תרופות ללא מרשם רפואי

Over-the-Counter Drug Prices in Israel are Much Higher Than Overseas

17.02.20|Orna Yefet
The Israeli Ministries of Health and Economy summoned OTC drug manufacturers and distributors for meetings after a study found prices are 37% higher on average in Israel
מוסף תרופה תרופות בית מרקחת

Teva Israel to Stop Distribution of Weight Loss Drug Amid Cancer Concerns

16.02.20|Lilach Baumer
On Thursday, the manufacturer of Belviq weight loss drug, Eisai, announced it was withdrawing the drug from the U.S. market after a five-year trial found it increased risk of cancer by 0.6%
קור שולץ מנכ"ל טבע 9.11.19

Teva’s Small Print Gives Rise to Optimism

13.02.20|Sophie Shulman
The improvement CEO Kåre Shultz promised is not immediately evident in the drugmaker’s forecast for 2020, but a closer look shows Teva’s new brand drugs are starting to live up to their promise
רינת רותם דוקטור סמנכלית מחקר ו פיתוח קיורטק מוטי חכם סמנכל כספים קיורטק בשיער לבן

CureTech’s Cancer-Fighting Dreams End With Insolvency

03.02.20|Lital Dobrovitsky
After an acquisition deal with pharmaceutical company InSight fell through in 2018, the company failed to secure further funding
נגיף קורונה סין

Coronavirus Shockwaves Already Felt in Israel

03.02.20|Adrian Filut and Tzally Greenberg
All Israelis returning from China will be subject to a two-week quarantine at home, under the Israeli Health Ministry’s supervision
וירוס קורונה סין מגיפה

As a Preemptive Measure, Israel Authorizes Forced Quarantine of Potential Coronavirus Carriers

28.01.20|Adrian Filut and Lilach Baumer
No confirmed cases of the pandemic have been recorded in Israel; the number of fatalities in China has now risen to 106
מוסף 3.5.18 בית חולים איכילוב תל אביב

Israel to Establish National Center for Proton Radiation Cancer Therapy

27.01.20|Adrian Filut
The Tel Aviv Sourasky Medical Center (Ichilov Hospital) has been chosen to operate the center, the construction of which is estimated at between $50 million and $100 million
אלטיבו קנאביס

Eltivu Wants to Develop an Espresso Machine-Like Device for Cannabis

26.01.20|Tzally Greenberg
The Tel Aviv-based startup is currently raising a first $1 million round to take its device from a prototype to a commercial venture
קור שולץ מנכ"ל טבע 9.11.19

Teva Fights Muddy Reputation With Positive Report

23.01.20|Sophie Shulman
Calcalist obtained a report commissioned by the Israeli drugmaker that details its economic contribution to the countries in which it operates
חממת גידול קנאביס

After a Year of Disappointments, the Israeli Cannabis Industry Pins its Hopes on 2020

22.01.20|Tzally Greenberg
Calcalist spoke with leading players of the local cannabis industry to see where the wind will blow in the upcoming year
עמיר לונדון מנכ"ל קמהדע

FIMI Makes $25 Million Private Placement in Biomed Company Kamada

22.01.20|Tzally Greenberg
Israel-based private equity fund FIMI became the largest shareholder in Nasdaq and Tel Aviv-listed Kamada in November
פיליפ סרלין ביוליין

BioLineRx’s Flagship Pancreas Cancer Drug Receives Orphan Drug Status in Europe

15.01.20|Tzally Greenberg
The clinical stage company’s drug received a similar designation in the U.S. last year
Previous ArticlesMore Articles